These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7922122)

  • 1. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
    Boger DL; Johnson DS; Yun W; Tarby CM
    Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunit.
    Boger DL; Zarrinmayeh H; Munk SA; Kitos PA; Suntornwat O
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1431-5. PubMed ID: 1847523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
    Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
    J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
    Boger DL; Johnson DS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions.
    Boger DL; Yun W; Han N; Johnson DS
    Bioorg Med Chem; 1995 Jun; 3(6):611-21. PubMed ID: 7582940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration and definition of the noncovalent binding selectivity of agents related to CC-1065 by an affinity cleavage agent: noncovalent binding coincidental with alkylation.
    Boger DL; Zhou J; Cai H
    Bioorg Med Chem; 1996 Jun; 4(6):859-67. PubMed ID: 8818235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
    Lee CS; Sun D; Kizu R; Hurley LH
    Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065.
    Park HJ
    Arch Pharm Res; 2002 Feb; 25(1):11-24. PubMed ID: 11885687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit.
    Boger DL; Yun W; Cai H; Han N
    Bioorg Med Chem; 1995 Jun; 3(6):761-7. PubMed ID: 7582954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noncovalent binding-translocation mechanism for site-specific CC-1065-DNA recognition.
    Gunz D; Naegeli H
    Biochem Pharmacol; 1996 Aug; 52(3):447-53. PubMed ID: 8687499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional 1H and 31P NMR spectra and restrained molecular dynamics structure of a covalent CPI-CDPI2-oligodeoxyribonucleotide decamer complex.
    Powers R; Gorenstein DG
    Biochemistry; 1990 Oct; 29(42):9994-10008. PubMed ID: 2271635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment.
    Needham-VanDevanter DR; Hurley LH
    Biochemistry; 1986 Dec; 25(26):8430-6. PubMed ID: 3030397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting.
    Ding ZM; Harshey RM; Hurley LH
    Nucleic Acids Res; 1993 Sep; 21(18):4281-7. PubMed ID: 8414983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity.
    Reynolds VL; Molineux IJ; Kaplan DJ; Swenson DH; Hurley LH
    Biochemistry; 1985 Oct; 24(22):6228-37. PubMed ID: 3002434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC-1065 bonding to intracellular and purified SV40 DNA: site specificity and functional effects.
    McHugh MM; Woynarowski JM; Mitchell MA; Gawron LS; Weiland KL; Beerman TA
    Biochemistry; 1994 Aug; 33(31):9158-68. PubMed ID: 8049219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA.
    Hurley LH; Sun D
    J Mol Recognit; 1994 Jun; 7(2):123-32. PubMed ID: 7826672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
    Boger DL; Hughes TV; Hedrick MP
    J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC-1065/duocarmycin and bleomycin A2 hybrid agents: lack of enhancement of DNA alkylation by attachment to noncomplementary DNA binding subunits.
    Boger DL; Han N
    Bioorg Med Chem; 1997 Feb; 5(2):233-43. PubMed ID: 9061188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.